2011-05-02

Visit us at CVS

2010-11-05

Join us at AMP

2010-02-01

The ELITech Group announces the sale of microarray assets to Gamida for Life

2009-10-26

ELITech announces its new product line: ELITech Molecular Diagnostics

2009-10-23

HandyLab Expands License and Supply Agreement

2009-06-25

ELITECH ACQUIRES NANOGEN'S ASSETS

2008-05-23

Nanogen Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market

2008-05-22

Nanogen Announces Consolidation of Point of Care Manufacturing Operations

2008-05-12

Nanogen Reports 2008 First Quarter Financial Results

2008-04-02

Nanogen and Thermo Fisher Scientific Partner to Provide Molecular Biology Products to Research Market

2008-03-31

DRI Capital Inc. Acquires Royalties from Nanogen Inc. for US $10 Million

2008-03-14

Nanogen Enters into Agreement to Restructure its Senior Convertible Notes

2008-03-13

Nanogen Reports 2007 Preliminary Fourth Quarter and Full Year Financial Results

2008-03-11

Nanogen to Host Fourth Quarter Conference Call March 13, 2008

2008-02-13

Nanogen Receives Final Stockholder Approval on Debt Financing

2008-02-01

Nanogen Receives Stockholder Approval on Two of Three Proposals and Adjourns Special Meeting to February 11, 2008

2008-01-31

Nanogen Patent Portfolio in Realtime PCR Strengthened

2008-01-31

Nanogen Patent Portfolio in Realtime PCR Strengthened

2007-12-14

Nanogen Announces Retirement of CFO; Appoints Successor

2007-12-11

Rosetta Genomics Selects PCR as Platform for its MicroRNA-Based Diagnostics to be Launched in 2008

2007-12-10

Nanogen, Inc. Files Preliminary Proxy Statement

2007-12-10

Nanogen Reaches Milestone in CDC Influenza Project

2007-11-28

Nanogen Strengthens Cardiac Biomarker Patent Position as US Patent Office Reissues Patent for Diagnosis of Chronic Congestive Heart Failure

2007-11-12

Nanogen Reports Third Quarter Financials

2007-11-12

Nanogen to Close Array Business - Will Focus on Two High Growth Product Lines

2007-11-09

Nanogen to Host Third Quarter Conference Call on November 12, 2007

2007-10-01

Nanogen Extends IP Portfolio with Nucleic Acid Detection and Genotyping Technology Patents

2007-10-01

Nanogen Extends IP Portfolio with Nucleic Acid Detection and Genotyping Technology Patents

2007-09-17

Nanogen to Focus on High Growth Clinical Diagnostics Markets with Real Time and Point of Care Products; Undertakes Evaluation of Strategic Alternatives for Microarray Business

2007-08-27

Nanogen Announces $20 Million Financing Transaction

2007-08-08

Nanogen Reports 2007 Second Quarter Financial Results

2007-08-06

Nanogen to Host Second Quarter Conference Call on August 8, 2007

2007-07-17

Nanogen Begins Shipment of Congestive Heart Failure Product

2007-07-11

Nanogen Gains Access to Schizophrenia Markers

2007-06-12

Nanogen Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics

2007-05-09

Nanogen Reports 2007 First Quarter Financial Results

2007-05-02

Nanogen to Host First Quarter Conference Call and Webcast on May 9, 2007

2007-04-17

Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip® 400 System

2007-04-04

Nanogen Obtains GSA Contract for NanoChip® 400 Platform

2007-02-28

Nanogen Awarded Patents for Biomarkers Associated with Diabetes, Alzheimers Disease

2007-02-20

Nanogen Reports 2006 Fourth Quarter and Year-End Financial Results

2007-02-19

Nanogen to Host Fourth Quarter Conference Call and Webcast on February 20, 2007

2007-01-31

Heller Presents Nanofabrication Advances Using Nanogen Technology at Lab Automation Conference

2006-12-06

Nanogen Releases Pharmacogenetics Research Reagents for CYP2C9 and VKORC1 Analysis

2006-12-04

Nanogen Wins CDC Contract to Develop Avian Flu Diagnostic

2006-11-01

Nanogen Reports 2006 Third Quarter Financial Results

2006-10-31

Heiner Dreismann, former Roche Executive, Joins Nanogen Board of Directors

2006-10-30

Nanogen to Host Third Quarter Conference Call and Webcast on November 1, 2006

2006-10-30

Nanogen Awarded Additional Patents for Diabetes, Alzheimers Disease Biomarkers

2006-10-05

Nanogen Announces Consolidation and Cost Reduction Actions

2006-10-05

Nanogen Announces Consolidation and Cost Reduction Actions

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-10-04

Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million

2006-09-06

New Patent Expands Nanogen's Core Nanotechnology Position

2006-08-24

Nanogen Earns Patents for use of Biomarkers Related to Diabetes and Alzheimers Disease

2006-08-23

Nanogen Expands Point-of-Care Product Line to Include Drugs of Abuse Tests

2006-08-09

Fisher Healthcare to Distribute Nanogen Real-Time PCR Products to Clinical Laboratories

2006-08-09

Nanogen Reports 2006 Second Quarter Financial Results

2006-08-09

Fisher Healthcare to Distribute Nanogen Real-Time PCR Products to Clinical Laboratories

2006-08-07

Nanogen to Host Second Quarter Conference Call and Webcast on August 9, 2006

2006-08-03

Nanogen and Fisher Scientific Expand Molecular Diagnostics R&D Collaboration Agreement

2006-07-13

Nanogen Releases New Real-Time PCR Reagents

2006-06-15

Nanogen Releases Enterovirus Reagent Employing Newly Patented Hybridization Technology

2006-05-15

Nanogen Announces Type II Diabetes Research Collaboration

2006-05-11

Nanogen Reports 2006 First Quarter Financial Results

2006-05-10

Nanogen Receives $25 Million Equity Financing Commitment

2006-05-08

Nanogen to Release First Quarter Financial Results and Host Webcast on May 11, 2006

2006-05-02

DrugMEt Pharmacogentics Product Achieves CE Mark for IVD Use

2006-04-25

Nanogen Expands Real-Time Portfolio with Release of Product for the Detection of Epstein-Barr Virus (EBV)

2006-04-20

Nanogen to Acquire European Molecular Diagnostics Company Amplimedical

2006-04-17

Nanogen Earns Two Patents for Therapeutic and Diagnostic Use of Biomarkers

2006-03-29

Nanogen Receives 510(K) Clearance for Congestive Heart Failure NT-proBNP Test

2006-03-23

Nanogen Launches Cystic Fibrosis Analyte Specific Reagents

2006-03-16

Nanogen Receives $15 Million Strategic Investment from Fisher

2006-03-13

Nanogen Issues Patent for Integrated Sample Preparation and Detection Device

2006-02-07

Nanogen Closes Acquisition of Point-of-Care Cardiac Diagnostic Test Business from Spectral Diagnostics

2005-12-22

Nanogen Expands Patent Portfolio in Genetic Analysis Technologies

2005-12-20

Nanogen and Spectral Announce Rapid Cardiac Diagnostic Test Agreement

2005-12-13

Nanogen Releases Two Products for the Detection of Respiratory Viral Pathogens

2005-11-17

Nanogen Issued Patent for Technology Enabling Assay Development to Detect Difficult Nucleic Acid Sequences

2005-11-08

Nanogen issued Patent for Key Component of Nanochip Electronic Microarray

2005-11-02

Nanogen Reports 2005 Third Quarter Financial Results

2005-11-01

Nanogen Point-of-Care Diagnostics Division Earns ISO Certification

2005-10-27

Nanogen to Release Third Quarter Financial Results and Host Webcast on Wednesday, November 2, 2005

2005-10-19

Nanogen Begins Shipments of NanoChip 400 Systems

2005-10-11

Nanogen Announces Patent for Fluorescent Detection of Nucleic Acid Targets

2005-09-28

Nanogen Announces $20 Million Common Stock Sale

2005-09-26

Nanogen Issued Patent for Kinase Screening Technology

2005-08-02

Nanogen Reports 2005 Second Quarter Financial Results

2005-08-02

Nanogen Reports 2005 Second Quarter Financial Results

2005-08-01

Nanogen Awarded $2.5 Million Grant for Development of Diagnostics for Sepsis and Pneumonia

2005-07-27

Nanogen to Release Second Quarter Financial Results and Host Webcast on Tuesday, August 2, 2005

2005-07-26

Nanogen Gains Access to Diagnostic Markers Through Investment in Jurilab

2005-07-07

Nanogen Issued Patent for Method of Monitoring PCR Using Fluorescent Energy Transfer